BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bayudan AM, Chen CH. Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities. World J Clin Cases 2020; 8(15): 3218-3229 [PMID: 32874976 DOI: 10.12998/wjcc.v8.i15.3218]
URL: https://www.wjgnet.com/1948-5182/full/v8/i15/3218.htm
Number Citing Articles
1
Gedefaw Getnet Amare, Birhanu Geta Meharie, Yaschilal Muche Belayneh. A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomideJournal of Oncology Pharmacy Practice 2021; 27(3): 673 doi: 10.1177/1078155220975825
2
Mengyuan Peng, Xiaozhong Guo, Fangfang Yi, Fernando Gomes Romeiro, Andrea Mancuso, Xingshun Qi. Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative ReviewAdvances in Therapy 2021; 38(10): 5065 doi: 10.1007/s12325-021-01912-6
3
Paraskevas Gkolfakis, Romane Fostier, Georgios Tziatzios, Nikolaos Lazaridis, Michael Fernandez Y Viesca, Antonio Facciorusso, Edward Despott, Konstantinos Triantafyllou, Jacques Devière, Marianna Arvanitakis. Efficacy of pharmacologic treatment for treating gastrointestinal angiodysplasias-related bleeding: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2022; 34(10): 1021 doi: 10.1097/MEG.0000000000002414
4
ThalidomideReactions Weekly 2021; 1857(1): 322 doi: 10.1007/s40278-021-96707-6
5
Geng Song, Fei‐Fei Zhang, Huai‐Dong Cheng. Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferationAustralasian Journal of Dermatology 2022; 63(2): 217 doi: 10.1111/ajd.13812